Cargando…
Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis
Aristolochic acid (AA) is considered to be a causative agent for progressive interstitial renal fibrosis, leading to AA nephropathy. Lysophosphatidic acid (LPA) is a mediator in the onset of renal fibrosis. In this study, we analyzed the molecular species of LPA and its precursor lysophospholipids i...
Autores principales: | Tsutsumi, Toshihiko, Yamakawa, Syougo, Ishihara, Akira, Yamamoto, Aimi, Tanaka, Tamotsu, Tokumura, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598376/ https://www.ncbi.nlm.nih.gov/pubmed/28962344 http://dx.doi.org/10.1016/j.toxrep.2015.02.012 |
Ejemplares similares
-
Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice
por: Urate, Shingo, et al.
Publicado: (2021) -
Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
por: Tokumura, Akira, et al.
Publicado: (2009) -
Association of lysophosphatidic acid molecules with liver fibrosis: different roles indicated
por: Tobita, Hiroshi, et al.
Publicado: (2023) -
Aristolochic acid exposure in Romania and implications for renal cell carcinoma
por: Turesky, Robert J, et al.
Publicado: (2016) -
Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy
por: Shui, Guang-xing, et al.
Publicado: (2017)